Sight Sciences, Inc. (SGHT) income statement
SGHTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30163% above fair value
$10.18−0.44 (-4.14%)
Close on Nov 20, 2026Market cap $560.80MP/E –Yield –
Sight Sciences, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 88.0%
- Operating margin
- -33.4%
- Net margin
- -35.7%
- Return on equity, FY2025
- -50.7%
Financial strength
- Current ratio
- 4.95
- Debt to equity
- 0.96
- Debt to assets
- 48.5%
- Cash to current liabilities
- 389.1%
Valuation
- P/E ratio
- –
- Price to sales
- 6.73
- Price to book
- 10.60
- Dividend yield
- –
See a number that looks wrong?